Increasing Knowledge and Interest in Cancer Clinical Trials
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Web-based Educational Intervention, Questionnaire Administration.
- Who it may be relevant to
- Registry conditions: Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm. Basic parameters: from 21 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
This trial investigates how well a video-based clinical trial education session works in increasing knowledge and interest in cancer clinical trials among individuals in the metropolitan Detroit region of the Karmanos Cancer Institute (KCI) catchment area. This educational activity may help researchers learn more about individuals' awareness of clinical trials, knowledge, and intention to participates in a clinical trial.
Detailed description
PRIMARY OBJECTIVE:
I. To increase cancer clinical trial knowledge and interest through video-based education among individuals aged 21 and older in the metropolitan Detroit region of the KCI catchment area.
OUTLINE:
Participants view educational video consisting of information on the purpose of clinical trials, myths associated with clinical trials, and how to find more information about clinical trials.
Interventions
- Other Web-based Educational Intervention
View web-based educational video - Other Questionnaire Administration
Pre video baseline survey and a post video educational survey
Primary outcome measures
- Increase in Clinical Trial Awareness and Knowledge [Time frame: Baseline and immediately post intervention up to 1 day]
Secondary outcome measures (1)
- Increase in intentions to participate in cancer clinical trials. [Time frame: Baseline and immediately post intervention up to 1 day]
Eligibility criteria
Inclusion criteria
- Individuals aged 21 and older
- Participants will be identified through Karmanos Cancer Institute's (KCI) clinical treatment center
- Participants will be identified through community-based KCI-sponsored events
- Participants will have voiced an interest to participate followed by an Informed consent
Exclusion criteria
- none
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Allocation
- N/A
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Health services research
Study locations
United States · 1 center
- Wayne State University/Karmanos Cancer Institute — Detroit
Identifiers
NCT: NCT06501040 · 2019-137 · NCI-2020-07119 · 2019-137 · P30CA022453